Haemonetics Corporation · NYSE:HAE

Kroll Mark W received 2,538 Haemonetics Corporation shares as an award (Form 4)

Traded Jul 24, 2026 · Filed Jul 28, 2026

On Jul 24, 2026, Kroll Mark W (Director) received 2,538 Haemonetics Corporation shares as an award, leaving 27,295 shares. Filed Jul 28, 2026 (Form 4).

Awarded
2,538 shares
Holding after
27,295 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 24, 2026Common StockAward2,53827,295Direct

Source

View original at SEC

Related